Interchange Capital Partners LLC Sells 3,274 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Interchange Capital Partners LLC significantly reduced its holdings in HCA Healthcare by 91.7%, selling 3,274 shares, and now owns only 297 shares valued at $114,000.
• HCA Healthcare recently reported quarterly earnings with an EPS of $6.84, exceeding analysts' estimates of $6.20, while its revenue was up 6.4% year-over-year.
• The company declared a quarterly dividend of $0.72 per share, providing a yield of 0.7%, with a dividend payout ratio currently at 12.11%.

Interchange Capital Partners LLC lessened its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 91.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 297 shares of the company's stock after selling 3,274 shares during the quarter. Interchange Capital Partners LLC's holdings in HCA Healthcare were worth $114,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Nuveen LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter valued at about $569,217,000. Pacer Advisors Inc. boosted its position in HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after buying an additional 1,329,618 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after acquiring an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after acquiring an additional 587,036 shares during the last quarter. Finally, Abdiel Capital Advisors LP bought a new position in shares of HCA Healthcare in the first quarter worth about $164,835,000. Institutional investors own 62.73% of the company's stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of HCA stock opened at $418.34 on Wednesday. The stock has a market cap of $97.89 billion, a P/E ratio of 17.58, a P/E/G ratio of 1.29 and a beta of 1.40. The company has a fifty day moving average price of $407.16 and a two-hundred day moving average price of $376.85. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $439.01.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the company posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on HCA shares. UBS Group boosted their price target on shares of HCA Healthcare from $438.00 to $495.00 and gave the stock a "buy" rating in a research note on Tuesday. Robert W. Baird upped their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research note on Thursday, August 14th. KeyCorp upped their price target on shares of HCA Healthcare from $370.00 to $465.00 and gave the company an "overweight" rating in a report on Wednesday, October 8th. Bank of America upped their price target on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a report on Wednesday, September 10th. Finally, Morgan Stanley reduced their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $431.07.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.